Risk modifiers in carriers of brca1 mutations

No abstract is available for this paper.

• Publication year

  1995

• Venue

  International Journal of Cancer

• Publication date

  1995-12-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ijc.2910640608PMID 8550241
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Parity, age at first childbirth, and risk of ovarian cancer

  1995cited by this paper
• Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1995cited by this paper
• Unusual case of Smith-Lemli-Opitz syndrome "type II".

  1995cited by this paper
• An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.

  1995cited by this paper
• A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.

  1995cited by this paper
• The impact of family history on ovarian cancer risk. The Utah Population Database.

  1995cited by this paper
• The genetic epidemiology of BRCA1. Breast Cancer Linkage Consortium.

  1994cited by this paper
• A large kindred with 17q-linked breast and ovarian cancer: genetic, phenotypic, and genealogical analysis.

  1994cited by this paper
• Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer

  1994cited by this paper
• Incidence of familial melanoma and MLM2 gene.

  1994cited by this paper
• Inherited predisposition to breast and ovarian cancer.

  1994cited by this paper
• Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families

  1994cited by this paper
• Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families

  1994cited by this paper
• The genetic epidemiology of BRCA1

  1994cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study.

  1994cited by this paper
• Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

  1993cited by this paper
• Epidemiology of ovarian cancer.

  1993cited by this paper
• Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group.

  1992cited by this paper
• Familial breast-ovarian cancer locus on chromosome 17q12-q23.

  1991cited by this paper
• The epidemiology of ovarian cancer.

  1991cited by this paper
• Linkage of early-onset familial breast cancer to chromosome 17q21.

  1990cited by this paper
• Interaction of familial and hormonal risk factors for breast cancer.

  1982cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• The risks of cancer in older women with BRCA pathogenic variants: How far have we come?

  2022cites this paper
• Putting It All Together

  2022cites this paper
• A Competing Risks Model with Time Varying Covariates for Estimation of Breast Cancer Risks in BRCA1 Families

  2020cites this paper
• Prediction of -association in hereditary non- breast carcinomas with array-CGH

  2020cites this paper
• Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance

  2020cites this paper
• High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer

  2019cites this paper
• Predictors of Lymph Node Metastasis in Primary Breast Cancer - Risk Models for Tailored Axillary Management

  2018cites this paper
• Breast Cancer Risks and Risk Prediction Models

  2015cites this paper
• The Genetics of Breast Cancer: What the Surgical Oncologist Needs to Know.

  2015cites this paper
• Familiärer Brustkrebs – empirische Erkrankungsrisiken und Risikoberechnungsmodelle

  2015cites this paper
• Genetic and functional characterization of candidate genes for complex psychiatric diseases using next-generation sequencing and cellular uptake assays

  2014cites this paper
• Estimate of the penetrance of BRCA mutation and the COS software for the assessment of BRCA mutation probability

  2014cites this paper
• BRCA1 und BRCA2 − genetische und nichtgenetische Einflussfaktoren

  2014cites this paper
• BRCA1 and BRCA2 Gene Mutations Screening In Sporadic Breast Cancer Patients In Kazakhstan

  2013cites this paper
• Hereditary gynaecological malignancies: advances in screening and treatment

  2013cites this paper
• Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium

  2013cites this paper
• Pregnancy after Breast Cancer: Myths and Facts

  2012cites this paper
• Prediction of "BRCAness" in breast cancer by array comparative genomic hybridization

  2012cites this paper
• AIB1 polymorphisms with breast cancer susceptibility: a pooled analysis of variation in BRCA1/2 mutation carriers and non–carriers

  2012cites this paper
• [Hereditary ovarian cancer. The role of BRCA1 gene dysfunction in response to chemotherapy].

  2011cites this paper
• [Risk assessment in familial breast cancer].

  2011cites this paper
• Serum levels of IGF-I and BRCA penetrance: a case control study in breast cancer families

  2011cites this paper
• Negotiation of Health Risks and Risk Management for Young Adult BRCA1/2-Positive Women: Implications for Partnering and Family Formation

  2010cites this paper
• Някои естетични и онкологични проблеми на онкопластичната хирургия на туморите в долните квадранти на млечната жлеза

  2009cites this paper
• Epigenetic targeting in breast cancer: therapeutic impact and future direction.

  2009cites this paper
• Oral Contraceptive Use and BRCA Penetrance: A Case-Only Study

  2009cites this paper
• Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and P53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers

  2009cites this paper
• Hereditary ovarian cancer.

  2009cites this paper
• Genetic Counseling and the Advanced Practice Oncology Nursing Role in a Hereditary Cancer Prevention Clinic: Hereditary Breast Cancer Focus (Part II)

  2009cites this paper
• Genetic Counseling and the Advanced Practice Oncology Nursing Role in a Hereditary Cancer Prevention Clinic: Hereditary Breast Cancer Focus (Part I)

  2009cites this paper
• Effect of Reproductive Factors and Oral Contraceptives on Breast Cancer Risk in BRCA1/2 Mutation Carriers and Noncarriers: Results from a Population-Based Study

  2008cites this paper
• Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer

  2008cites this paper
• Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH

  2008cites this paper
• Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers

  2008cites this paper
• BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors

  2007cites this paper
• The Genetic Epidemiology of Hereditary Breast Cancer

  2007cites this paper
• Consultation d'oncogénétique pour le cancer du sein

  2007cites this paper
• Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

  2007cites this paper
• [Oncogenetic consultation for breast cancer].

  2007cites this paper
• Diagnostic des patientes à risque de cancer du sein

  2006cites this paper
• Ovarian cancer.

  2006cites this paper
• Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention

  2006cites this paper
• Sein et hormones

  2006cites this paper
• Systemic therapy for gynecological neoplasms: ovary, cervix, and endometrium.

  2006cites this paper
• Cause-specific mortality of grand multiparous women in Finland.

  2006cites this paper
• Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).

  2006cites this paper
• Hereditary Breast and Ovarian Cancer: Structures of Care in Austria

  2006cites this paper
• BRCA1--a good predictive marker of drug sensitivity in breast cancer treatment?

  2006cites this paper
• Tests de prédisposition génétique aux cancers du sein

  2006cites this paper
• Gene–environment interactions in human diseases

  2005cites this paper
• A weighted cohort approach for analysing factors modifying disease risks in carriers of high‐risk susceptibility genes

  2005cites this paper
• Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene

  2005cites this paper
• Prédisposition génétique au cancer du sein : quels gènes et quelles valeurs de risque tumoral ?

  2005cites this paper
• Modifying effect of reproductive risk factors on the age at onset of breast cancer for GermanBRCA1 mutation carriers

  2005cites this paper
• Ataxia-Telangiectasia genes and breast cancer risk in a French family study

  2005cites this paper
• Hereditary ovarian cancer.

  2005cites this paper
• Towards a dietary prevention of hereditary breast cancer.

  2005cites this paper
• Risk factors and prognostic factors in patients with double primary cancer: epithelial ovarian cancer and breast cancer.

  2005cites this paper
• Review The influence of familial and hereditary factors on the prognosis of breast cancer

  2005cites this paper
• Younger birth cohort correlates with higher breast and ovarian cancer risk in European BRCA1 mutation carriers

  2005cites this paper
• Brief Report: Towards a dietary prevention of hereditary breast cancer

  2005cites this paper
• BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy.

  2005cites this paper
• Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

  2005cites this paper
• [BRCA1: from the gene identification to the cancer risk estimation].

  2004cites this paper
• Hereditary breast cancer in Jews

  2004cites this paper
• Genetic Predisposition to Male and Female Breast Cancer

  2004cites this paper
• Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.

  2004cites this paper
• Hereditary ovarian cancer in Ashkenazi Jews

  2004cites this paper
• Chapter 28 – Molecular Biology and Molecular Genetics of Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

  2004cites this paper
• BRCA1: de l’identification du gène à l’estimation des risques tumoraux

  2004cites this paper
• Epidemiology of breast cancer among BRCA mutation carriers: an overview.

  2004cites this paper
• BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations.

  2003cites this paper
• BRCA2 mutation carriers, reproductive factors and breast cancer risk

  2003cites this paper
• A qualitative study looking at the psychosocial implications of bilateral prophylactic mastectomy.

  2003cites this paper
• Peut-on prévenir chimiquement le cancer du sein en 2003 ?

  2003cites this paper
• [Can breast cancer be chemoprevented in 2003?].

  2003cites this paper
• Prophylactic oophorectomy: why and when?

  2003cites this paper
• Systemic therapy for gynecological neoplasms: ovary, cervix and endometrium.

  2003cites this paper
• Prophylactic mastectomy: why and when?

  2003cites this paper
• BRCA2mutation carriers, reproductive factors and breast cancer risk

  2003cites this paper
• BRCA 1 Wild-Type Allele Modifies Risk of Ovarian Cancer in Carriers of BRCA 1 GermLine Mutations 1

  2003cites this paper
• Diagnostic génétique du cancer du sein et de l’ovaire héréditaire*

  2003cites this paper
• Breast cancer: occurrence, risk factors and hormone metabolism

  2003cites this paper
• Antisense oligonucleotides as therapeutics for the treatment of aggressive breast cancer

  2002cites this paper
• Inherited predisposition and breast cancer: Modifiers of BRCA1/2‐associated breast cancer risk

  2002cites this paper
• Change in the penetrance of founder BRCA1/2 mutations? A retrospective cohort study

  2002cites this paper
• Familial risks of breast cancer

  2002cites this paper
• Epithelial Ovarian Carcinoma and Fertility of Parents

  2002cites this paper
• A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers.

  2002cites this paper
• Oral contraceptives and risk of familial breast cancer.

  2002cites this paper
• Breast Cancer Risk in Ashkenazi BRCA1/2 Mutation Carriers: Effects of Reproductive History

  2002cites this paper
• Risk assessment & genetic testing.

  2002cites this paper
• Molecular aspects of ovarian cancer.

  2002cites this paper
• Genetic risk in context: calculating the penetrance of BRCA1 and BRCA2 mutations.

  2002cites this paper
• Modifiers of risk of hereditary breast and ovarian cancer

  2002cites this paper
• The genetics of ovarian cancer.

  2002cites this paper
• Variation in breast cancer risk of heterozygotes for ataxia‐telangiectasia according to environmental factors

  2002cites this paper
• Association of Parity and Ovarian Cancer Risk by Family History of Breast or Ovarian Cancer in a Population-Based Study of Postmenopausal Women

  2002cites this paper
• Breast Cancer and Pregnancy

  2002cites this paper
• Epithelial ovarian carcinoma and fertility of parents.

  2002cites this paper